Hello, Welcome to Shine Consultant !
Summit & Event Advisor & Insight Research & Analysis
  • 首页
Asia Pharma  Manufacturing Congress 2020

Asia Pharma  Manufacturing Congress 2020


Time: 5th -6th, Aug., 2020

Address: Shanghai · China

Topic: Look at the New Regulation Policy, Process Technology, Quality Standards and Cooperation Opportunities in Asia


The Asia Pharma Manufacturing Congress 2020 is one of the high-level strategic summits in the pharmaceutical industry in Asia. The top four global pharmaceutical markets are the United States, China, five European countries and Japan. Asia has an important status in the global pharmaceutical market and is growing rapidly. In recent years, the Chinese state has frequently issued policies on the pharmaceutical industry, vigorously reformed and pushed the policies into practice. 

Conference Overview

【Event Background】


The Asia Pharma Manufacturing Congress 2020 is one of the high-level strategic summits in the pharmaceutical industry in Asia. The top four global pharmaceutical markets are the United States, China, five European countries and Japan. Asia has an important status in the global pharmaceutical market and is growing rapidly. In recent years, the Chinese state has frequently issued policies on the pharmaceutical industry, vigorously reformed and pushed the policies into practice. For instance, The Quality Consistency Evaluation for Generic Drugs, Drugs Centralized Purchase, the introduction of the ‘Pharmaceutical Administration Law’, and the full implementation of the Marketing Authorization Holder system (MAH) have profound influence on upstream and downstream enterprises in the industrial chain: the level of pharmaceutical preparations has been significantly improved; the quality of medicines can be ensured; the internationalization process and industrial structural reforms has been accelerated; and the industry concentration has been greatly increased, avoiding duplication of production capacity.


This conference will bring together experts, executives and decision makers from major domestic pharmaceutical companies, multinational pharmaceutical companies, biotechnology companies, scientific research institutes, API and pharmaceutical excipients manufacturers, CMO / CDMO and other contract outsourcing companies, pharmaceutical manufacturing equipment and pharmaceutical packaging companies, to jointly discuss hot topics in the industry. This conference will provide a broad stage for cooperation in order to promote the development of the Asian pharmaceutical industry, the implementation of policies and regulations, optimize industrial layout, grasp trends, deepen internal management and external cooperation.


【Key Topics】


>>In-depth interpretation of policy reform in the pharmaceutical industry and comprehensive analysis of the pharmaceutical manufacture ecosystem.

>>Converge many experts in the pharmaceutical industry to discuss challenges and solutions in the pharmaceutical manufacture process.

>>Share the manufacturing management experience under the new policies, synergize and promote pharmaceutical manufacturing efficiency and capacity upgrades.

>>Focus on the latest technology developments in the pharmaceutical industry and accelerate the optimization of pharmaceutical manufacturing processes.

>>Discuss the construction of the manufacturing quality management system to ensure the quality and safety of drugs

>>Explore the layout of the pharmaceutical industry, grasp the current status and future trends of the pharmaceutical industry chain to realize green and sustainable development.


【Who Should Attend】

Asia Pharma  Manufacturing Congress 2020


【Your Chances to Meet】

Asia Pharma  Manufacturing Congress 2020

Asia Pharma  Manufacturing Congress 2020

Asia Pharma  Manufacturing Congress 2020


【Event Highlights】

Asia Pharma  Manufacturing Congress 2020

Event Organizer

Asia Pharma  Manufacturing Congress 2020

Asia Pharma  Manufacturing Congress 2020
Conference Organizer / Co-Organizer

Asia Pharma  Manufacturing Congress 2020

Guidance / co-sponsor / support
<
  • RDPAC
  • 上海医药行业协会
  • 中国化学制药工业协会
>
Speakers
  • Joe ZHOU President & CSO Genor Biopharma Co. Ltd, Walvax Bio Group
  • Jerry YANG SVP, Process Development Transcenta Holding Ltd.
  • Weichang ZHOU Chief Technology Officer Executive Vice President, WuXi Biologics
  • Simon XU SVP of Technical Operations Henlius Biotech Inc.
  • Jingrong LI SVP, Product Development and Manufacturing Cstone Pharmaceuticals
  • Donald Palahnuk VP LSPD-TT (MST) Top Ailliance
  • Zhenping WU SVP, Pharmaceutical Sciences Hutchison MediPharma
  • Xun LIU Vice President, President of BioMedicine Developme Jiangsu Hengrui Medicine Co.,Ltd.
  • Yangyu WAN Deputy General Manger Kelun Pharmaceutical Group
  • Yuxiang ZHANG Deputy General Manger North China Pharmaceutical  Group Co.,Ltd.
  • Deping DU General Manager Shandong Xinhua Pharmaceutical Co., Ltd.
  • Hao HONG Chairman & CEO Asymchem Group
  • Jin SHE Vice President, Chemistry Hua Medicine
Cooperative Media
    药学进展
    发布时间: 2020 - 04 - 17
    药学进展
    亿欧大健康
    发布时间: 2020 - 04 - 17
    亿欧大健康
    时代财经
    发布时间: 2020 - 04 - 17
    时代财经
    BioSeedin
    发布时间: 2020 - 04 - 09
    BioSeedin
    Lingmed
    发布时间: 2019 - 07 - 11
    Lingmed is a young, professional and fast growing company, it promotes world best in class intelligence databases to healthcare industry and provide with its premium services – Linkedbio - which provides analytical services and reports to help our clients to make better decisions and support BD sourcing activities.
    Global Data
    发布时间: 2020 - 04 - 09
    Global Data
    Insight-China Pharma Data
    发布时间: 2019 - 07 - 11
    Insight-China Pharma Data, presented by DXY elite team, focusing on collect and analyse medical information and digging insight from vast data.We already have more than 80 thounsands corporate and individual customers, including pharma company, CRO, financial institutions, helping them with product registration, progress, results, patent, bidding, government regulation, industry news and professional consulting service.
    前瞻网
    发布时间: 2019 - 10 - 31
    www.qianzhan.com
    Pharmacodia (Beijing) Co., Ltd. (“Pharmacodia”)
    发布时间: 2019 - 07 - 11
    Founded in 2013, Pharmacodia (Beijing) Co., Ltd. (“Pharmacodia”) is China’s first pharmaceutical R&D big data company.  Pharmacodia has successfully created a comprehensive information service platform in the biomedicine field.  Based on in depth analysis of pharmaceutical R&D Data, the company provides service including database support, drug news, R&D resources.  Pharmacodia has become the 'Leader' of China's pharmaceutical information provider. Pharmacodia products have covered more than 140 countries and are widely used in government agencies, university research institutes, drug research and development companies, investment and financing institutions.  Pharmacodia was awarded 'ZHONGGUANCUN Pharmaceutical R&D Big-Data Platform' and 'National Hi...
    医谷
    发布时间: 2019 - 07 - 11
    医谷
    云掌财经
    发布时间: 2019 - 11 - 22
    云掌财经
    Chinese Journal of Biologicals
    发布时间: 2019 - 07 - 11
    Chinese Journal of Biologicals, hereinafter referred to as Journal, is under the leadership of Ministry of Health of the People's Republic of China and sponsored by China Preventive Medicine Association. It mainly reports information of China biologicals, important R&D achievements and latest progresses of biologicals,as well as the status of worldwide biological and biotechnology products. The main readers of it are production, research and management personnel who come from biological and biotechnology products enterprises, clinician, and government officials who take charge of verification, disease surveillance and control.Biologicals, which are used for the prevention, treatment and diagnose of human disease, are produced of microorganism, cell and animal or human tissue and b...
    Interfax
    发布时间: 2019 - 11 - 22
    Interfax Group is a leading provider of critical information on Russia, China and emerging markets of Eurasia, serving the diverse needs of investors, corporations, financial professionals and the media. Interfax provides about 100 specialized information services, supplying weekly and daily intelligence reports with industry analysis, business information, real-time news, market data and ratings and credit reports. The leader in the CIS, the Interfax Group has a global operational network, with over 1000 staff daily turning out over 3000 stories from over 70 bureaus worldwide. We've covered Banking & finance, oil & gas, energy, power, mining & metals, food & agriculture, pharmaceutical & health sciences, telecoms media technology (TMT), Insurance, in addition to many o...
    GBI
    发布时间: 2019 - 07 - 31
    Founded in Shanghai in 2002, GBI has built a diverse portfolio of market intelligence solutions for pharmaceutical and device companies and other service providers. Focused on China and the Latin American markets, GBI’s value-added industry information, news, and data services power individuals and organizations’ decision-making and enable more effective communication. As a trusted source of information, GBI has established long-term relationships with both multinational players and local firms, and continues to drive forward the health care industry.GBI has offices in Shanghai, Beijing, and Washington D.C.
Agenda
Travel & Stay

For More Information, please contact us
Liz LI
T: +86 21 60957201  
E: 
liz.li@shine-consultant.com